Anthem Biosciences (ANTHEMBIOS) is a Healthcare sector company on NSE. Latest filed quarter: Q2 FY27, revenue ₹611 Cr, net profit ₹187 Cr, EPS ₹64.20.
Dashboard / Healthcare
Anthem Biosciencesi
ANTHEMBIOS.NS · NSE · ISIN INE000LSSVXO
Updated 0D ago
Trading priceOPEN
₹842.00-0.6%
vs previous close ₹846.77
Day high
₹858.48
Day low
₹838.10
Volume
76.6 L
Illustrative price data for this demo. Not real-time and not intended for trading.
Latest quarter
Q2 FY27
30 Sep 2026
Revenue
₹611 Cr
+30.5% YoY
Net profit
₹187 Cr
+138.1% YoY
EPS
₹64.20
vs Q2 FY26
Exchange
NSE
Sector
Healthcare
Industry
CRAMS
Market cap
₹2,455 Cr
ISIN
INE000LSSVXO
NSE symbol
ANTHEMBIOS
BSE scrip
—
Next results
—
Revenue by quarter
Last 15Net profit by quarter
Last 15Quarter-by-Quarter
7 quarters| Quarter | Period end | Revenue | QoQ | YoY | Net profit | Profit YoY | Op. profit | EPS | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Q2 FY27 | 30 Sep 2026 | ₹611 Cr | +9.1% | +30.5% | ₹187 Cr | +138.1% | ₹341 Cr | 64.20 | 05 Oct 2026 |
| Q1 FY27 | 30 Jun 2026 | ₹560 Cr | -2.5% | +30.0% | ₹146 Cr | +131.3% | ₹267 Cr | 50.21 | 23 Jul 2026 |
| Q4 FY26 | 31 Mar 2026 | ₹574 Cr | +11.3% | +35.1% | ₹136 Cr | +149.5% | ₹248 Cr | 46.70 | 21 May 2026 |
| Q3 FY26 | 31 Dec 2025 | ₹516 Cr | +10.1% | — | ₹100 Cr | — | ₹183 Cr | 34.43 | 19 Feb 2026 |
| Q2 FY26 | 30 Sep 2025 | ₹468 Cr | +8.7% | — | ₹79 Cr | — | ₹143 Cr | 26.97 | 16 Nov 2025 |
| Q1 FY26 | 30 Jun 2025 | ₹431 Cr | +1.3% | — | ₹63 Cr | — | ₹115 Cr | 21.70 | 17 Aug 2025 |
| Q4 FY25 | 31 Mar 2025 | ₹425 Cr | — | — | ₹55 Cr | — | ₹100 Cr | 18.71 | 18 May 2025 |
Last updated 05 Oct 2026. Season progress: 84 of 114 tracked companies have filed Q4 FY26.
FAQ
About Anthem Biosciences
India Earnings Tracker is a free, live dashboard of quarterly results for 1,000+ listed Indian companies on NSE and BSE. We aggregate revenue, net profit, operating profit, EPS, and YoY/QoQ growth for every reporting quarter, with direct links to the original filing PDFs. No paywall, no broker estimates — only filed, official numbers from the exchanges.